(S,R,S)-AHPC-C3-NH2

Background Introduction

(S,R,S)-AHPC-C3-NH2 is a specialized bifunctional molecule designed for use in targeted protein degradation research, particularly in the development of PROTACs (Proteolysis Targeting Chimeras). This compound consists of the potent VHL (von Hippel-Lindau) E3 ligase ligand, (S,R,S)-AHPC, tethered to an amino-terminated C3 linker, enabling facile conjugation with target-binding ligands. The high specificity and optimized linker length make it a valuable building block for generating novel PROTACs compatible with a variety of protein targets.

Mechanism

The mechanism of (S,R,S)-AHPC-C3-NH2 centers on targeted protein degradation via the ubiquitin-proteasome system. In PROTAC design, this linker conjugate acts as the E3 ligase-recruiting component. Upon conjugation with a suitable ligand for the protein of interest, the resulting PROTAC molecule bridges the target protein to the VHL E3 ligase. This proximity promotes the ubiquitination of the target, effectively marking it for degradation by the cellular proteasome machinery. The C3 linker provides optimal spacing and flexibility for efficient formation of the ternary complex, facilitating selective and rapid target protein elimination.

Applications

(S,R,S)-AHPC-C3-NH2 is widely applied in medicinal chemistry, drug discovery, and chemical biology research. Its primary use is as a modular component in the synthesis of VHL-based PROTACs for targeted protein degradation. Researchers utilize this linker conjugate to design and optimize PROTACs aimed at diverse disease-relevant proteins, enabling the study of protein function, target validation, and development of first-in-class therapeutic candidates. Additionally, (S,R,S)-AHPC-C3-NH2 can serve in the generation of tool compounds for probing biological pathways and proteostasis mechanisms.

The E3 Ligase Ligand-Linker Conjugate (S,R,S)-AHPC-C3-NH2 plays a crucial role in PROTACs by facilitating targeted protein degradation through its unique structure and reactivity. This molecule's design enhances the efficiency of protein degradation, making it a valuable tool for researchers exploring novel therapeutic strategies. The following provides a detailed description of this molecule.

Linker: The linker in (S,R,S)-AHPC-C3-NH2 is a three-carbon chain, providing moderate length and flexibility. This flexible linker facilitates optimal positioning between the ligand and the target protein, ensuring effective binding and degradation. It is non-cleavable, maintaining the stability of the conjugate throughout the degradation process.

Ligand: The ligand component is based on AHPC, a derivative that exhibits high binding affinity and specificity for the E3 ligase. Its stereochemistry is carefully designed to enhance interaction with the ligase, promoting efficient ubiquitination of the target protein.

Reactive Site: The reactive site in this molecule is an amine group, which couples effectively with electrophilic groups on the target protein ligand. Recommended reaction types include amide bond formation or reductive amination, which provide robust and stable linkages essential for PROTAC function.

Recommended Target Protein Ligand: The compatible warhead for (S,R,S)-AHPC-C3-NH2 is typically an electrophilic moiety capable of forming covalent bonds with the reactive amine site. This enables precise targeting and degradation of specific proteins, offering advantages in studying protein function and developing potential therapeutic interventions. Researchers can exploit this specificity to investigate various cellular pathways and disease mechanisms.